TRPV3 regulates Breast Cancer Cell Proliferation and Apoptosis by EGFR/AKT pathway
Journal of Cancer · 2024 · 15 (10) · 2891-2899
DOI: 10.7150/jca.93940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer, 2024. Verfasst von Yan Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medicine College of Daqing Campus, Harbin Medical University-Daqing, Daqing, 163319, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Basic Medicine College of Daqing Campus, Harbin Medical University-Daqing, Daqing, 163319, China.
- Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, 02215, United States of America.
- Department of Pharmacy, The First Affiliated Hospital, Jinan University, Guangzhou, 510630, China.
- The Guangzhou Key Laboratory of Basic and Translational Research on Chronic Diseases, Jinan University, Guangzhou, 510630, China.
- Department of Pharmacology, Hainan Medical University, Haikou, 571199, China.
Zitieren
APA
Xie, Y., Kim, H. I., Yang, Q., Wang, J., & Huang, W. (2024). TRPV3 regulates Breast Cancer Cell Proliferation and Apoptosis by EGFR/AKT pathway. Journal of Cancer, 15(10), 2891-2899. https://doi.org/10.7150/jca.93940
Vancouver
Xie Y, Kim HI, Yang Q, Wang J, Huang W. TRPV3 regulates Breast Cancer Cell Proliferation and Apoptosis by EGFR/AKT pathway. Journal of Cancer. 2024;15(10):2891-2899. doi:10.7150/jca.93940
BibTeX
@article{Xie2024,
author = {Xie, Yan and Kim, Hyo In and Yang, Qianzhi and Wang, Jinghao and Huang, Wei},
title = {TRPV3 regulates Breast Cancer Cell Proliferation and Apoptosis by EGFR/AKT pathway},
journal = {Journal of Cancer},
year = {2024},
volume = {15},
number = {10},
pages = {2891--2899},
doi = {10.7150/jca.93940}
}
EUVIMED